BSECompany Update22 Aug 2026 · 22 Aug 2026, 04:32 pm
Announcement under SEBI Listing Regulations regarding Schedule of Institutional Investor Meet.
Global Health Ltd · 543654
✦ AI SummaryRegulatory
Global Health Ltd has announced an institutional investor meet, scheduled for August 26 and 27, 2026, where the company's management will meet with investors and analysts. The meeting will be held in physical mode, and no unpublished price-sensitive information will be shared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
737cfac4-eb13-4e64-b88c-56205c4cd12c.pdf
View document text
Date: August 22, 2026
Ref:- GHL/2026-27/EXCH/47
The General Manager The Manager
Dept. of Corporate Services Listing Department
BSE Limited, National Stock Exchange of India Limited
P J Towers, Dalal Street, Exchange Plaza, C-1, Block G,
Mumbai - 400 001 Bandra Kurla Complex,
Bandra (E), Mumbai - 400 051
Scrip Code: 543654 Symbol: MEDANTA
Sub: Intimation for Schedule of Analyst/Institutional Investor Meeting.
Dear Sir(s),
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will
meet Investor/Analyst in Meeting organised as per the below schedule:
Name Date of Meeting Type of Meeting Mode of Meeting
Motilal Oswal Financial Services August 26,2026 one to one Physical
Limited
Motilal Oswal Financial Services August 27,2026 one to one Physical
Limited
Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat.
Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on
the part of Analysts/Investors/Company.
Kindly take the above on record.
For Global Health Limited
Rahul Ranjan
Company Secretary & Compliance Officer
M. No. A17035
Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319